HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Diphenhydramine and hyaluronic acid derivatives reduce adnexal adhesions and prevent tubal obstructions in rats.

AbstractOBJECTIVE:
The purpose of this study is to investigate the effects of diphenhydramine-HCl and Na-hyaluronate derivatives on the development of postoperative peritoneal adhesion and tubal obstruction.
STUDY DESIGN:
Forty female rats of Sprague-Dawley type were used in the study. The rats were divided into four groups, each comprising 10 subjects. After all the rats were anaesthetized with 50mg/kg ketamine HCl, their abdomens were opened with a lower midline incision. Injury was induced on the right pelvic peritoneum and on the peritoneal surface of left uterine tube. No additional procedure was applied to the first group. 10 mg/kg diphenhydramine-HCl was given to the second group intravenously. In the third group, 0.25 mg/kg Orthovisc, a Na-hyaluronate derivative was diluted with 2 ml physiological saline and poured into the abdomen. For the fourth group, Seprafilm, a Na-hyaluronate derivative was covered in a layer of 0.7 cm x 3 cm over the left uterine tube. After 14 days, the rats were anaesthetized with ketamine HCl again, and 5 cm(3) blood sample was taken with cardiac puncture. The abdomen was opened with an incision transverse to the upper end of the midline incision, and the presence of adhesions was investigated. Detected adhesions were staged according to the Mazuji classification. Tubal patencies were inspected by injecting methylene blue from the uterine corpus into the lumen using an injector. A piece of abdominal wall of 4 cm x 4 cm was removed by extending the incision in the reverse U shape. The tensile strength and bursting pressure of the suture line were determined using the Peacock method. One gram of tissue was taken from the incision line, and hydroxyproline levels were determined by the Bergman-Loxley method. Aspartate aminotransferase (AST) levels were measured.
RESULTS:
All of the rats completed the study. AST levels, tissue hydroxyproline levels and tensile strength and bursting pressure test results were found to be similar in all groups. While adhesion rates in the groups were 100, 40, 40 and 30%, respectively, adhesion stages were found to be, respectively as 2.1+/-1.7, 0.6+/-0.67, 0.6+/-0.67 and 0.5+/-0.85. Adhesion stages in the study groups were significantly lower (P<0.05). Tubal obstruction rates were found to be 70, 30, 30 and 20%, respectively.
CONCLUSION:
Diphenhydramine, Orthovisc and Seprafilm significantly reduce postoperative peritoneal adhesion development, and they allow the uterine tubes to remain open.
AuthorsAyse Filiz Avsar, Fatih Mehmet Avsar, Mustafa Sahin, Serdar Topaloglu, Husamettin Vatansev, Metin Belviranli
JournalEuropean journal of obstetrics, gynecology, and reproductive biology (Eur J Obstet Gynecol Reprod Biol) Vol. 106 Issue 1 Pg. 50-4 (Jan 10 2003) ISSN: 0301-2115 [Print] Ireland
PMID12475581 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • Biocompatible Materials
  • Histamine H1 Antagonists
  • Membranes, Artificial
  • Seprafilm
  • orthovisc
  • Diphenhydramine
  • Hyaluronic Acid
  • Aspartate Aminotransferases
  • Hydroxyproline
Topics
  • Adnexal Diseases (prevention & control)
  • Animals
  • Aspartate Aminotransferases (drug effects)
  • Biocompatible Materials (pharmacology)
  • Diphenhydramine (pharmacology)
  • Fallopian Tube Diseases (prevention & control)
  • Fallopian Tube Patency Tests
  • Female
  • Histamine H1 Antagonists (pharmacology)
  • Hyaluronic Acid (analogs & derivatives, pharmacology)
  • Hydroxyproline (drug effects)
  • Laparotomy (adverse effects)
  • Membranes, Artificial
  • Rats
  • Rats, Sprague-Dawley
  • Tensile Strength (drug effects)
  • Tissue Adhesions (prevention & control)
  • Wound Healing (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: